Digital metabolic care startup Twin Health announced it has raised $140 million in Series C funding for global growth.
The round includes investment from ICONIQ Growth, Sequoia Capital India, Perceptive Advisors, Corner Ventures, LTS Investments, Helena and Sofina.
Twin’s product is the Whole Body Digital Twin, an AI-backed model that aims to provide individualized nutrition, sleep and activity guidelines to help people prevent and reverse metabolic diseases like Type 2 diabetes.
“The Whole Body Digital Twin became my life’s work after my eyes were opened to the magnitude of chronic disease globally. I had seen too many loved ones impacted by the daily challenges of living with these diseases, forever changing the futures they imagined,” founder and CEO Jahangir Mohammed said in a statement.
“The impact the Twin service has had on our members’ lives energizes and inspires me, hearing their stories as they begin to understand the intricacies of their own metabolism and feel empowered to heal from the inside out.”
Decentralized clinical trial platform Lightship scooped up $40 million in new funding.
The round was led by Define Ventures and Brook Byers, with participation from Khosla Ventures, McKesson Ventures and TIME Ventures.
The capital will go towards the company’s international expansion. It plans to open a new office this fall in London. Lightship has also been expanding its leadership team, hiring, for example, a new chief financial officer.
The most recent round builds on a $20 million raise announced in February 2020.
“Today, only a small proportion of the global patient population has access to clinical trials as a treatment option. This new investment, plus the expansion of our team, enables Lightship to grow internationally and continue our journey to give patients everywhere the opportunity to participate in clinical research,” CEO David MacMurchy said in a statement.
“This is such an exciting, fast-growing market and at Lightship we have amazing teams committed to our mission and going beyond expectations for patients and sponsors of clinical studies.”
Brave Care, a digital pediatric clinic, announced Thursday it has raised $25 million in new funding.
The round was led by Mednax. Dr. Jim Swift, Mednax’s chief development officer, has joined Brave Care’s Board of Directors.
“With this exciting investment, Brave Care is now even better positioned to open more pediatric facilities around the country, elevating care experiences and dramatically increasing the chance that every kid reaches their full potential,” Darius Monsef, CEO of Brave Care, said in a statement.
“We created Brave Care from the experience that every parent needs a trusted partner in their child’s medical team, and that every child deserves access to excellent care regardless of their family’s financial position. Sharing this intention in partnership with Mednax, we foresee this as a clear opportunity to open over 100 new clinics in the next few years.”
Pivotal Analytics, maker of a healthcare analytics platform that helps organizations predict supply and demand needs, completed a $10.2 million Series A round.
The capital infusion will go towards improving its platform by expanding its number of data partners and proprietary algorithms, as well as redesigning its experience for different types of users. Pivotal also wants to make new hires, including ones in product development and engineering.
“Pivotal integrates specialized healthcare and real estate data in unique ways to deliver strategic insights and a better perspective for healthcare opportunities,” CEO Carl Davis said in a statement.
“It’s extremely validating to have industry leaders recognize the value of our platform, and we are thrilled to benefit from their advice and experience as we help our customers make better real estate and operational decisions.”
Femtech startup Tuune closed a $4.6 million funding round for hormone analysis and personalized birth control recommendations.
The round was led by Octopus Ventures, and the funds will go toward the company’s launch in the U.S.
“At Tuune, our goal is to improve the healthcare experience for women, starting with technology that empowers them to make more informed birth control choices. We want to move away from centuries of ignoring the impact of female hormones on 50% of the population.
“It’s important to recognize that our hormones play a fundamentally important role in our overall health, and we can use them to live better. It’s time to get answers, speak up, and expect more,” cofounder Shardi Nahavandi said in a statement.
NowRx, an online pharmacy that offers same-day delivery, is accepting reservations for a $73 million Series C round through crowdfunding platform SeedInvest.
It said $8 million has already been committed.
Once the round is completed, NowRx plans to use the funds to expand into new locations and speed up innovation for its pharmacy management software and logistics technology.
“The current pandemic raised the bar for telehealth services and pharmacy delivery. Patients now expect speed, reliability, convenience and quality,” NowRx CEO Cary Breese said in a statement. “This crowdfunding round will help us bring our services to new markets while still prioritizing the high quality customer experience that has earned us so many five star reviews.”